APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchTetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) include Whistler, The Lab, Select Oil, Pharmahemp, NuLeaf Naturals, Medical Marijuana, Kazmira, K.I.N.D. Concentrates and HempLife Today, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tetrahydrocannabinol (THC) and Cannabidiol (CBD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market size, projected growth trends, production technologies, key applications, and end-use industries.

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Company

Whistler

The Lab

Select Oil

Pharmahemp

NuLeaf Naturals

Medical Marijuana

Kazmira

K.I.N.D. Concentrates

HempLife Today

Green Road

Freedom Leaf

Folium Biosciences

ENDOCA

Emblem Cannabis Oils

CW Hemp/CW Botanicals

CBD American Shaman

Canopy Growth Corporation

Cannavest

Aphria

Absolute Terps

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Type

Tetrahydrocannabinol (THC)

Cannabidiol (CBD)

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Application

Pharmaceuticals Industry

Food Industry

Cosmetics Industry

Other

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tetrahydrocannabinol (THC) and Cannabidiol (CBD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Trends Table 2. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Drivers Table 3. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Opportunities and Challenges Table 4. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Restraints Table 5. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Manufacturers Table 9. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers, Product Type & Application Table 13. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tetrahydrocannabinol (THC) Table 17. Major Manufacturers of Cannabidiol (CBD) Table 18. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 20. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2027-2032) & (Tons) Table 21. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2021-2026) Table 22. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2027-2032) Table 23. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2026) & (Tons) Table 25. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2027-2032) & (Tons) Table 26. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2021-2026) Table 27. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pharmaceuticals Industry Table 29. Major Manufacturers of Food Industry Table 30. Major Manufacturers of Cosmetics Industry Table 31. Major Manufacturers of Other Table 32. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 34. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2027-2032) & (Tons) Table 35. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2021-2026) Table 36. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2027-2032) Table 37. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2026) & (Tons) Table 39. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2027-2032) & (Tons) Table 40. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2021-2026) Table 41. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2027-2032) Table 42. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021-2026) & (Tons) Table 44. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2021-2026) Table 45. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecasted by Region (2027-2032) & (Tons) Table 46. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 48. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 49. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 50. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 51. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 52. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 53. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 55. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 56. South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 57. South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 58. South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 59. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region (2021-2026) Table 63. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region (2027-2032) Table 64. Whistler Company Information Table 65. Whistler Business Overview Table 66. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 68. Whistler Recent Development Table 69. The Lab Company Information Table 70. The Lab Business Overview Table 71. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 73. The Lab Recent Development Table 74. Select Oil Company Information Table 75. Select Oil Business Overview Table 76. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 78. Select Oil Recent Development Table 79. Pharmahemp Company Information Table 80. Pharmahemp Business Overview Table 81. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 83. Pharmahemp Recent Development Table 84. NuLeaf Naturals Company Information Table 85. NuLeaf Naturals Business Overview Table 86. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 88. NuLeaf Naturals Recent Development Table 89. Medical Marijuana Company Information Table 90. Medical Marijuana Business Overview Table 91. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 93. Medical Marijuana Recent Development Table 94. Kazmira Company Information Table 95. Kazmira Business Overview Table 96. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 98. Kazmira Recent Development Table 99. K.I.N.D. Concentrates Company Information Table 100. K.I.N.D. Concentrates Business Overview Table 101. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 103. K.I.N.D. Concentrates Recent Development Table 104. HempLife Today Company Information Table 105. HempLife Today Business Overview Table 106. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 108. HempLife Today Recent Development Table 109. Green Road Company Information Table 110. Green Road Business Overview Table 111. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 113. Green Road Recent Development Table 114. Freedom Leaf Company Information Table 115. Freedom Leaf Business Overview Table 116. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 118. Freedom Leaf Recent Development Table 119. Folium Biosciences Company Information Table 120. Folium Biosciences Business Overview Table 121. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 123. Folium Biosciences Recent Development Table 124. ENDOCA Company Information Table 125. ENDOCA Business Overview Table 126. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 128. ENDOCA Recent Development Table 129. Emblem Cannabis Oils Company Information Table 130. Emblem Cannabis Oils Business Overview Table 131. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 133. Emblem Cannabis Oils Recent Development Table 134. CW Hemp/CW Botanicals Company Information Table 135. CW Hemp/CW Botanicals Business Overview Table 136. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 138. CW Hemp/CW Botanicals Recent Development Table 139. CBD American Shaman Company Information Table 140. CBD American Shaman Business Overview Table 141. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 143. CBD American Shaman Recent Development Table 144. Canopy Growth Corporation Company Information Table 145. Canopy Growth Corporation Business Overview Table 146. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 148. Canopy Growth Corporation Recent Development Table 149. Cannavest Company Information Table 150. Cannavest Business Overview Table 151. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 153. Cannavest Recent Development Table 154. Aphria Company Information Table 155. Aphria Business Overview Table 156. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 158. Aphria Recent Development Table 159. Absolute Terps Company Information Table 160. Absolute Terps Business Overview Table 161. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 163. Absolute Terps Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors List Table 167. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Image Figure 2. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size (2021-2032) & (US$ Million) Figure 4. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (2021-2032) & (Tons) Figure 5. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tetrahydrocannabinol (THC) Image Figure 9. Cannabidiol (CBD) Image Figure 10. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 11. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2021-2032) Figure 13. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2021-2032) Figure 16. Pharmaceuticals Industry Image Figure 17. Food Industry Image Figure 18. Cosmetics Industry Image Figure 19. Other Image Figure 20. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2021-2032) Figure 23. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 24. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2021-2032) Figure 26. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 27. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2032) Figure 28. U.S. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Canada Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Mexico Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 32. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2032) Figure 33. Germany Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 34. France Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 35. U.K. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Italy Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Netherlands Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2032) Figure 40. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Japan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 42. South Korea Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 44. India Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 45. Australia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 46. South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2032) Figure 48. Brazil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 49. South Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Saudi Arabia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Turkey Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Argentina Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 53. UAE Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Egypt Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Chile Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Figure 59. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Figure 61. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tetrahydrocannabinol (THC)
  • Cannabidiol (CBD)
Applications
  • Pharmaceuticals Industry
  • Food Industry
  • Cosmetics Industry
  • Other
Companies covered
  • Whistler
  • The Lab
  • Select Oil
  • Pharmahemp
  • NuLeaf Naturals
  • Medical Marijuana
  • Kazmira
  • K.I.N.D. Concentrates
  • HempLife Today
  • Green Road
  • Freedom Leaf
  • Folium Biosciences
  • ENDOCA
  • Emblem Cannabis Oils
  • CW Hemp/CW Botanicals
  • CBD American Shaman
  • Canopy Growth Corporation
  • Cannavest
  • Aphria
  • Absolute Terps

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Dynamics
  1. 2.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Trends
  2. 2.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Drivers
  3. 2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Opportunities and Challenges
  4. 2.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Restraints
3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Manufacturers
  1. 3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers, Product Type & Application
  7. 3.7 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Tier 1, Tier 2, and Tier 3
4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Type
  1. 4.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Type Introduction
  2. 4.1.1 Tetrahydrocannabinol (THC)
  3. 4.1.2 Cannabidiol (CBD)
  4. 4.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type
  5. 4.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2032)
  7. 4.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type
  9. 4.3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2032)
  11. 4.3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2021-2032)
5 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Application
  1. 5.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Application Introduction
  2. 5.1.1 Pharmaceuticals Industry
  3. 5.1.2 Food Industry
  4. 5.1.3 Cosmetics Industry
  5. 5.1.4 Other
  6. 5.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application
  7. 5.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2032)
  9. 5.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application
  11. 5.3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2032)
  13. 5.3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2021-2032)
6 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region
  1. 6.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021-2032)
  3. 6.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021-2026)
  4. 6.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region
  1. 7.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region
  2. 7.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2021-2026)
  4. 7.1.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2027-2032)
  5. 7.1.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032)
  8. 7.2.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032)
  11. 7.3.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Whistler
  2. 8.1.1 Whistler Company Information
  3. 8.1.2 Whistler Business Overview
  4. 8.1.3 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  6. 8.1.5 Whistler Recent Developments
  7. 8.2 The Lab
  8. 8.2.1 The Lab Company Information
  9. 8.2.2 The Lab Business Overview
  10. 8.2.3 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  12. 8.2.5 The Lab Recent Developments
  13. 8.3 Select Oil
  14. 8.3.1 Select Oil Company Information
  15. 8.3.2 Select Oil Business Overview
  16. 8.3.3 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  18. 8.3.5 Select Oil Recent Developments
  19. 8.4 Pharmahemp
  20. 8.4.1 Pharmahemp Company Information
  21. 8.4.2 Pharmahemp Business Overview
  22. 8.4.3 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  24. 8.4.5 Pharmahemp Recent Developments
  25. 8.5 NuLeaf Naturals
  26. 8.5.1 NuLeaf Naturals Company Information
  27. 8.5.2 NuLeaf Naturals Business Overview
  28. 8.5.3 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  30. 8.5.5 NuLeaf Naturals Recent Developments
  31. 8.6 Medical Marijuana
  32. 8.6.1 Medical Marijuana Company Information
  33. 8.6.2 Medical Marijuana Business Overview
  34. 8.6.3 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  36. 8.6.5 Medical Marijuana Recent Developments
  37. 8.7 Kazmira
  38. 8.7.1 Kazmira Company Information
  39. 8.7.2 Kazmira Business Overview
  40. 8.7.3 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  42. 8.7.5 Kazmira Recent Developments
  43. 8.8 K.I.N.D. Concentrates
  44. 8.8.1 K.I.N.D. Concentrates Company Information
  45. 8.8.2 K.I.N.D. Concentrates Business Overview
  46. 8.8.3 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  48. 8.8.5 K.I.N.D. Concentrates Recent Developments
  49. 8.9 HempLife Today
  50. 8.9.1 HempLife Today Company Information
  51. 8.9.2 HempLife Today Business Overview
  52. 8.9.3 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  54. 8.9.5 HempLife Today Recent Developments
  55. 8.10 Green Road
  56. 8.10.1 Green Road Company Information
  57. 8.10.2 Green Road Business Overview
  58. 8.10.3 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  60. 8.10.5 Green Road Recent Developments
  61. 8.11 Freedom Leaf
  62. 8.11.1 Freedom Leaf Company Information
  63. 8.11.2 Freedom Leaf Business Overview
  64. 8.11.3 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  66. 8.11.5 Freedom Leaf Recent Developments
  67. 8.12 Folium Biosciences
  68. 8.12.1 Folium Biosciences Company Information
  69. 8.12.2 Folium Biosciences Business Overview
  70. 8.12.3 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  72. 8.12.5 Folium Biosciences Recent Developments
  73. 8.13 ENDOCA
  74. 8.13.1 ENDOCA Company Information
  75. 8.13.2 ENDOCA Business Overview
  76. 8.13.3 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  78. 8.13.5 ENDOCA Recent Developments
  79. 8.14 Emblem Cannabis Oils
  80. 8.14.1 Emblem Cannabis Oils Company Information
  81. 8.14.2 Emblem Cannabis Oils Business Overview
  82. 8.14.3 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  84. 8.14.5 Emblem Cannabis Oils Recent Developments
  85. 8.15 CW Hemp/CW Botanicals
  86. 8.15.1 CW Hemp/CW Botanicals Company Information
  87. 8.15.2 CW Hemp/CW Botanicals Business Overview
  88. 8.15.3 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  90. 8.15.5 CW Hemp/CW Botanicals Recent Developments
  91. 8.16 CBD American Shaman
  92. 8.16.1 CBD American Shaman Company Information
  93. 8.16.2 CBD American Shaman Business Overview
  94. 8.16.3 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  96. 8.16.5 CBD American Shaman Recent Developments
  97. 8.17 Canopy Growth Corporation
  98. 8.17.1 Canopy Growth Corporation Company Information
  99. 8.17.2 Canopy Growth Corporation Business Overview
  100. 8.17.3 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  102. 8.17.5 Canopy Growth Corporation Recent Developments
  103. 8.18 Cannavest
  104. 8.18.1 Cannavest Company Information
  105. 8.18.2 Cannavest Business Overview
  106. 8.18.3 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  108. 8.18.5 Cannavest Recent Developments
  109. 8.19 Aphria
  110. 8.19.1 Aphria Company Information
  111. 8.19.2 Aphria Business Overview
  112. 8.19.3 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  114. 8.19.5 Aphria Recent Developments
  115. 8.20 Absolute Terps
  116. 8.20.1 Absolute Terps Company Information
  117. 8.20.2 Absolute Terps Business Overview
  118. 8.20.3 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  120. 8.20.5 Absolute Terps Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Value Chain Analysis
  2. 9.1.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Production Mode & Process
  6. 9.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors
  9. 9.2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst